A
Ayesha Zahid
Researcher at University of Science and Technology of China
Publications - 33
Citations - 687
Ayesha Zahid is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 19 publications receiving 242 citations. Previous affiliations of Ayesha Zahid include University of Lahore.
Papers
More filters
Journal ArticleDOI
Pharmacological Inhibitors of the NLRP3 Inflammasome.
TL;DR: This paper will review the various pharmacological inhibitors of the NLRP3 inflammasome and will also discuss their mechanism of action.
Journal ArticleDOI
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.
Arnaud John Kombe Kombe,Bofeng Li,Ayesha Zahid,Hylemariam Mihiretie Mengist,Guy-Armel Bounda,Ying Zhou,Tengchuan Jin,Tengchuan Jin +7 more
TL;DR: In this article, features of the cervicovaginal microbiota are found to be associated with the incidence of HPV-related diseases, presenting a novel approach to identify high-risk women through both blood and cervical samples.
Journal ArticleDOI
Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity.
TL;DR: By comprehensive understanding of molecular and structural aspects of DNA-sensing antiviral innate immune signaling pathways, potential new targets for viral and autoimmune diseases can be identified.
Posted ContentDOI
Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China
Zonghao Zhao,Jiajia Xie,Ming Yin,Yun Yang,Hongliang He,Tengchuan Jin,Wenting Li,Xiaowu Zhu,Jing Xu,Changcheng Zhao,Lei Li,Yi Li,Hylemariam Mihiretie Mengist,Ayesha Zahid,Ziqin Yao,Chengchao Ding,Yingjie Qi,Yong Gao,Xiaoling Ma +18 more
TL;DR: It is concluded that COVID-19 could cause different degrees of hematological abnormalities and damage of internal organs andAntiviral treatment requires a comprehensive and supportive approach.
Journal ArticleDOI
Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases.
Mahmood Rasool,Arif Malik,Tariq Tahir Butt,Muhammad Abdul Basit Ashraf,Rabia Rasool,Ayesha Zahid,Sulayman Waquar,Muhammad Asif,Ahmad Zaheer,Abdul Jabbar,Maryam Zain,Asim Mehmood,Tahira Batool Qaisrani,Imran Riaz Malik,Samiullah Khan,Zeenat Mirza,Absarul Haque,Mohammed H. Al-Qahtani,Sajjad Karim +18 more
TL;DR: This study provides strong evidence that CVD patients presented with elevated oxidative stress, enhanced inflammation and lipid profile in their serum, and strongly approves that AGEs, AOPPs, inflammatory and lipoxidative biomarkers hold predictive potential in causing and aggravating the disease.